Literature DB >> 16556266

Systemic effects of oral tolerance on inflammation: mobilization of lymphocytes and bone marrow eosinopoiesis.

Claudiney M Rodrigues1, Olindo A Martins-Filho, Nelson M Vaz, Cláudia R Carvalho.   

Abstract

Oral tolerance is a T-cell mediated phenomenon defined by inhibition of immune responsiveness to a protein previously contacted by the oral route. Oral tolerance may prevent autoimmune and allergic diseases that involve the recruitment and/or activation of different cell types including mast cells, neutrophils, eosinophils, monocytes and lymphocytes. The mechanisms by which oral tolerance avoids these immunological disorders are still controversial. Herein we used a murine model of ovalbumin (OVA)-induced peritonitis to investigate the effect of oral tolerance on allergic inflammation. Frequency of leucocyte subpopulations was evaluated by global and differential cell counts in peritoneal lavage fluid, peripheral blood, and bone marrow. Changes on lymphocyte subsets and adhesion molecules expression by these cells were analysed by flow cytometry. As compared with OVA-immune mice, intraperitoneal challenge of tolerant animals with OVA resulted in a significantly milder peritonitis, mostly affecting neutrophils and eosinophils; a concomitant reduction in total white blood cell counts was also observed, mainly because of lower neutrophil and eosinophil counts. Eosinophils, but not neutrophils, were also reduced in the bone-marrow of OVA-challenged tolerant mice. No changes occurred in total peritoneal lymphocyte counts in OVA-tolerant mice, however, there was a significant decrease in CD3+ CD8+ T cells and an increase in B cells (CD45R+) in these animals as compared to immune OVA-challenged animals. Altered expression of CD18 and CD54, respectively, in blood and peritoneal lymphocytes was also noted. These results suggest that, in addition to local specific effects, oral tolerance has systemic effects on the mobilization of leucocytes and bone-marrow eosinopoiesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556266      PMCID: PMC1782253          DOI: 10.1111/j.1365-2567.2006.02327.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

Review 1.  Oral tolerance: mechanisms and therapeutic applications.

Authors:  A M Faria; H L Weiner
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

Review 2.  Current issues in the treatment of human diseases by mucosal tolerance.

Authors:  Howard L Weiner
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

3.  Interruption of recently induced immune responses by oral administration of antigen.

Authors:  A A Conde; B Stransky; A M Faria; N M Vaz
Journal:  Braz J Med Biol Res       Date:  1998-03       Impact factor: 2.590

Review 4.  Immaturity, ageing and oral tolerance.

Authors:  N Vaz; A M Faria; B A Verdolin; C R Carvalho
Journal:  Scand J Immunol       Date:  1997-09       Impact factor: 3.487

5.  Indirect effects of oral tolerance cannot be ascribed to bystander suppression.

Authors:  C R Carvalho; B A Verdolin; N M Vaz
Journal:  Scand J Immunol       Date:  1997-03       Impact factor: 3.487

6.  Prevention of lung eosinophilic inflammation by oral tolerance.

Authors:  M Russo; S Jancar; A L Pereira de Siqueira; J Mengel; E Gomes; S M Ficker; A M Caetano de Faria
Journal:  Immunol Lett       Date:  1998-03       Impact factor: 3.685

7.  Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge.

Authors:  M I Gaspar Elsas; D Joseph; P X Elsas; B B Vargaftig
Journal:  Am J Respir Cell Mol Biol       Date:  1997-10       Impact factor: 6.914

8.  TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia.

Authors:  K Haneda; K Sano; G Tamura; T Sato; S Habu; K Shirato
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

9.  Activated mast cells release biological activities able to support eosinophil production from mouse hemopoietic precursors.

Authors:  C Oskéritzian; G Milon; P Braquet; J M Mencia-Huerta; B David
Journal:  Cell Immunol       Date:  1996-02-01       Impact factor: 4.868

10.  Indirect effects of oral tolerance in mice.

Authors:  C R Carvalho; B A Verdolin; A V de Souza; N M Vaz
Journal:  Scand J Immunol       Date:  1994-06       Impact factor: 3.487

View more
  5 in total

1.  Cell-mediated immune response to unrelated proteins and unspecific inflammation blocked by orally tolerated proteins.

Authors:  Gustavo C Ramos; Claudiney M Rodrigues; Geraldo M Azevedo; Vanessa Pinho; Cláudia R Carvalho; Nelson M Vaz
Journal:  Immunology       Date:  2008-08-28       Impact factor: 7.397

2.  Indirect effects of oral tolerance inhibit pulmonary granulomas to Schistosoma mansoni eggs.

Authors:  Geraldo Magela Azevedo; Raquel Alves Costa; Mariana Araujo Resende; Claudiney Melquiades Rodrigues; Nelson Monteiro Vaz; Cláudia Rocha Carvalho
Journal:  Clin Dev Immunol       Date:  2011-10-13

3.  Modulation of the effects of lung immune response on bone marrow by oral antigen exposure.

Authors:  P Xavier-Elsas; C L C A Silva; L Pinto; T Queto; B M Vieira; M G Aranha; B De Luca; D Masid-de-Brito; R A Luz; R S Lopes; R Ferreira; M I Gaspar-Elsas
Journal:  Biomed Res Int       Date:  2013-09-22       Impact factor: 3.411

4.  Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice.

Authors:  Lisiery N Paiatto; Fernanda G D Silva; Julia Bier; Márcia R Brochetto-Braga; Áureo T Yamada; Wirla M S C Tamashiro; Patricia U Simioni
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

5.  Subcutaneous injection of an immunologically tolerated protein up to 5 days before skin injuries improves wound healing.

Authors:  K Franco-Valencia; I B C Nóbrega; T Cantaruti; A Barra; A Klein; G M Azevedo-Jr; R A Costa; C R Carvalho
Journal:  Braz J Med Biol Res       Date:  2022-02-09       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.